Abstract: Among 307 patients enrolled in an HIV preexposure prophylaxis (PrEP) program in the Public Health-Seattle & King County STD Clinic, 52 patients (17%) did not fill their PrEP prescription and 40% of those who started PrEP discontinued it at least once within 12 months.
METHODS
The PHSKC PrEP program is integrated with STD clinic operations and provides PrEP to men who have sex with men (MSM) and transgender individuals who have sex with men at high risk for HIVaccording to King County and Washington State PrEP implementation guidelines. 8 This includes patients who have had rectal gonorrhea or syphilis, used methamphetamine or amyl nitrates, or provided sex for money or drugs in the last 12 months and patients in sexual relationships with HIV-infected persons who are not virally suppressed. In 2017, with the goal of improving equity in access to PrEP, the program expanded to provide PrEP to all interested black and Latino MSM or transgender individuals who have sex with men. Sexually transmitted disease clinicians and disease intervention specialists (DIS) refer patients who are interested in PrEP but do not meet the previously mentioned criteria to other providers in the community. Preexposure prophylaxis is widely available in King County, and uptake is relatively high. 9 All clinicians in the PHSKC STD Clinic can prescribe PrEP, and the goal is to provide a same-day prescription. Two DIS coordinate the program, assist patients with enrollment in payment assistance programs, schedule follow-up appointments at the time of each visit, and attempt to contact and reschedule all patients who miss appointments. After enrollment, patients follow up in clinic at 1 month then every 3 months with DIS. Clinicians see patients every 6 months or as needed. Patients who enroll in a text message support program receive automated appointment reminders, monthly 2-way check-in messages, and the opportunity to initiate 2-way text communication with the coordinators. Enrollment in the text message program is associated with retention in the PrEP program. 10 We conducted a retrospective cohort analysis of MSM who completed at least one PrEP encounter during the period October 2014 through December 2016. The PrEP coordinators record patient information in an electronic database, including the medication start date (verified pharmacy pick-up date), dates of completed appointments, and the status of PrEP use at each visit (continuing, stopped, restarted). When a patient reports discontinuing PrEP, either during or between visits, the DIS record the patient-reported discontinuation date and reason for discontinuation. The DIS ask about discontinuation reasons with an open-ended question and code the reason in the database according to defined categories or, for reasons not included in the list, in a free-text field. Patients who do not complete a scheduled follow-up visit and do not respond to 3 calls or text messages are classified as lost to follow-up.
For this analysis, we defined patient disengagement as either failure to start PrEP after enrolling, discontinuation of PrEP after initiation, or loss to follow-up. We excluded patients known to have moved away or transferred care because we could not determine the status of PrEP continuation. We determined the received a speaker's honorarium and travel support from Gilead for meetings on retention in HIV care. All other authors report no conflicts of interest. These findings were presented in part at the World STI Congress and HIVpercentage of patients who disengaged and assessed the timing of discontinuation using a Kaplan-Meier analysis. We examined differences by race/ethnicity and age in the prevalence of and reasons for disengagement (χ 2 tests) and the timing of discontinuation (log-rank test). To assess the extent to which patients in the PrEP program represent those at risk for HIV, we compared PrEP patients with MSM newly diagnosed as having HIV in King County 2011-2015 11 using a χ 2 test for race/ethnicity and t test for age.
RESULTS
During the 27-month analysis period, 334 MSM enrolled in the PrEP program. The race/ethnicity of PrEP patients differed from the population of newly diagnosed MSM in King County in 2011 through 2015 (N = 925), with a higher proportion of Hispanic patients in the PrEP program (24% vs. 15%; P < 0.001), but lower proportions of non-Hispanic black persons (8% vs. 12%, P = 0.048) and non-Hispanic white persons (52% vs. 62%; P < 0.001). Preexposure prophylaxis patients were younger than the newly HIV diagnosed (mean [SD] age, 29 [9] years vs. 36 [11] years; P < 0.001).
Twenty-seven men moved or transferred care (Fig. 1) . Among the 307 men in the analysis population, the median observation time was 12 months (interquartile range, 6-18 months). A total of 133 men (n = 43%) disengaged from the PrEP program: 52 (17% of the overall population) never started PrEP and 81 (32% of those who started PrEP; 26% of the overall population) discontinued after starting. The timing of PrEP discontinuation was relatively steady throughout the observation period (Fig. 2) , with 40% discontinuing at least once by 12 months. Discontinuation, noninitiation, and the timing of discontinuation were not associated with race/ethnicity or age (data not shown).
We were unable to determine patients' reasons for discontinuing because most who did so were lost to follow-up (n = 41), recorded as discontinuing for unknown reasons (n = 5), or were missing information (n = 7). Of the 28 patients with complete data, 13 (46%) discontinued because they were in a monogamous relationship with an HIV-seronegative partner, 4 (14%) stated that they were otherwise no longer at risk for HIV, and 11 (39%) discontinued due to adverse effects. Reasons for discontinuation did not vary by race/ethnicity or age (data not shown).
DISCUSSION
We found that among 307 MSM in the PrEP program, 17% never filled their prescription, and 40% of those who started PrEP discontinued it at least once within 12 months. Our finding of 17% noninitiation was similar to Chan and colleagues's 5 report of 19% noninitiation among persons prescribed PrEP in 3 US cities. Our finding of 40% discontinuation in 12 months was similar to recent reports from San Francisco community-based sexual health clinics (38% discontinuation in 13 months), 4 and publicly funded safety net clinics (33% discontinuation at a mean of approximately 8 months), 12 but somewhat higher than that reported from a pharmacy-based program in Seattle (25% in 1 year), 13 an online survey of MSM in Washington State (20% in 1 year), 14 and an integrated health system in California (23% in 9 months). 15 Higher discontinuation rates among STD clinic patients might reflect a higher-risk patient population or, at least in our clinic, promotion of PrEP to persons who did not come to clinic specifically seeking PrEP and are ambivalent about it.
The generalizability of our study is limited because it included only one clinic recruiting high-risk patients. We could not determine the reasons for disengagement for most patients due to loss to follow-up, and we did not independently assess ongoing risk among patients who reported that they were no longer at risk for HIV. The prevalence of treatment-limiting adverse effects in our analysis is difficult to interpret in the context of missing data on those lost to follow-up.
Our study suggests that patient retention in STD clinic PrEP programs is suboptimal, but without more information about why patients stop taking PrEP, this is uncertain. Discontinuation is appropriate for patients who are no longer at risk for HIV, but patients may not accurately perceive their risk. Available data suggest that at least some portion of discontinuation is not attributable to decreased risk. Patients with STDs 4 and drug or alcohol use 15 are less likely to stay on PrEP, and both younger age 7 and black race 12 are associated with drop-off of the PrEP care continuum. A better understanding of the relative contributions of health systems and patient factors to PrEP discontinuation is needed to inform the development of interventions to support patient PrEP engagement.
